01-Feb-17 The Middle East region, which includes some countries that are a target of Trump's ban, is the top source of patients who travel to the US for medical care. The travel ban could prompt international patients to skip the US and take their dollars elsewhere, such as to Germany or Thailand. [image: Wikimedia Commons]

26-Jan-17 The medical and surgical aesthetics market grew a further 8.3 percent in 2016. Representing 46 percent of global market share, the USA still leads the way, followed by Europe, Asia-Pacific and Latin America, according to annual figures from IMCAS. Global growth is above all driven by Asia, which saw annual growth of 10 percent in 2016. [image: The Malay Mail Online]

26-Jan-17 Verily, the Alphabet subsidiary formerly known as Google Life Sciences, has raised USD800 mn in funding from Temasek, the Singapore government investment company. "Proceeds may be used to support our growth in key strategic areas, including potential acquisitions, investment in partnerships and developing new opportunities on a global scale," according to a spokesperson for Verily. [image: Verily]

24-Jan-17 GE Healthcare had a strong 2016 fourth quarter performance led by 19 percent growth in China. For 2017, the company expects momentum to carry over for markets in China, Africa, and Asia Pacific, while Europe will be stable. The United States market is expected to slow down. Sales were boosted by ultrasound, up 6 percent, and imaging, up 2 percent. [image: GE Healthcare]

20-Jan-17 Private jet company L’Voyage is seeing growing interest in overseas medical and wellness trips from China. The ultra-rich prefer to fly by private jet and are increasingly choosing Europe and the US for treatments, drugs and technologies not available in China. Global Growth Markets estimates that 4,300 ultra-rich Chinese sought treatments overseas in 2015. [image: International Medical Travel Journal]